Two gene therapies for sickle cell disease approved by FDA
Two gene therapies for the treatment of sickle cell disease have been approved by the US Food and Drug Administration...
Two gene therapies for the treatment of sickle cell disease have been approved by the US Food and Drug Administration...
Methods for modelling development, including stem-cell-based embryo models, have been named Method of the Year by Nature Methods...
by Yan Lau
A gene therapy treatment for sickle cell disease has led to a build-up of cells with genetic mutations that make them grow faster, increasing blood-cancer risk, researchers revealed...
CRISPR/Cas9 genome editing can result in the unintended deletion of a region associated with cancer...
A CRISPR-based gene therapy for two blood disorders has been authorised by the UK medicines regulator...
by Olivia Goff
CRISPR base editing therapy reduced cholesterol levels in the blood of a small cohort of patients, clinical trial interim data has shown...
A CRISPR-based treatment for sickle cell disease is one step closer to approval after an advisory committee for the US Food and Drug Administration met to review its safety...
Early safety data of a potential CRISPR-based genome editing therapy for HIV have been reported...
Six perspectives on the ethical questions around genome editing are explored in this film commissioned by the Francis Crick Institute...
Macaque monkeys have become some of the longest-surviving recipients of cross-species organ transplants, after receiving genome-edited pig kidneys...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.